# Clinical Study on Autologous Stromal Vascular Fraction(SVF) Treatment for Refractory Benign Airway Stenosis and Respiratory Tract Fistula

> **NCT05270850** · NA · UNKNOWN · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 20 (estimated)

## Conditions studied

- Benign Airway Stenosis
- Respiratory Tract Fistula

## Interventions

- **PROCEDURE:** Control group
- **PROCEDURE:** SVF group

## Key facts

- **NCT ID:** NCT05270850
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-20
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270850, "Clinical Study on Autologous Stromal Vascular Fraction(SVF) Treatment for Refractory Benign Airway Stenosis and Respiratory Tract Fistula". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05270850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*